Authors: Gupta, S Banfield, C Kantesaria, B Marino, M Clement, R Affrime, M Batra, V

Citation: S. Gupta et al., Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: A randomized, placebo-controlled, parallel-group study, CLIN THER, 23(3), 2001, pp. 451-466

Authors: Ezzet, F Wexler, D Statkevich, P Kosoglou, T Patrick, J Lipka, L Mellars, L Veltri, E Batra, V

Citation: F. Ezzet et al., The plasma concentration and LDL-C relationship in patients receiving ezetimibe, J CLIN PHAR, 41(9), 2001, pp. 943-949

Authors: Barrett, JS Batra, V Chow, A Cook, J Gould, AL Heller, AH Lo, MW Patterson, SD Smith, BP Stritar, JA Vega, JM Zariffa, N

Citation: Js. Barrett et al., PhRMA perspective on population and individual bioequivalence, J CLIN PHAR, 40(6), 2000, pp. 561-570

Authors: Barrett, JS Batra, V Chow, A Cook, J Gould, AL Heller, AH Lo, MW Patterson, SD Smith, BP Stritar, JA Vega, JM Zariffa, N

Citation: Js. Barrett et al., Update to the PhRMA Perspective on Population and Individual Bioequivalence, J CLIN PHAR, 40(6), 2000, pp. 571-572

Authors: Baker, SD Wirth, M Statkevich, P Reidenberg, P Alton, K Sartorius, SE Dugan, M Cutler, D Batra, V Grochow, LB Donehower, RC Rowinsky, EK

Citation: Sd. Baker et al., Absorption, metabolism, and excretion of C-14-temozolomide following oral administration to patients with advanced cancer, CLIN CANC R, 5(2), 1999, pp. 309-317

Authors: Brada, M Judson, I Beale, P Moore, S Reidenberg, P Statkevich, P Dugan, M Batra, V Cutler, D

Citation: M. Brada et al., Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies, BR J CANC, 81(6), 1999, pp. 1022-1030